Kibow® Biotech Launches Renadyl® Advanced Multivitamin for Kidney Health
Kibow Biotech announced the launch of Renadyl® Advanced Multivitamin for Kidney Health. It is the first and only gummy multivitamin specially formulated for people managing chronic kidney disease (CKD) or end-stage renal disease (ESRD).
The #1 Nephrologist-Recommended Kidney Probiotic Renadyl® is Back in Stock
Kibow® Biotech has announced that its popular kidney health supplement, Renadyl™, is back in stock and will remain consistently available, due to expanded domestic manufacturing capabilities.
Kibow Pharmaceuticals Announces Completion of First Patient in Phase II, 6 Months RCT of US-APR2020 and Enrollment in Subsequent 6 Months Open-Label Trial, a Unique Design of a Best-in-Class Add-on Treatment for Chronic Kindy Disease Patients
Kibow Pharmaceuticals LLC is a phase 2/3 clinical-stage company focused on developing novel live biotherapeutic products (LBP) for chronic kidney disease (CKD) patients. Kibow’s first clinical product, US-APR2020, is in a phase 2b multi-site global clinical trial and has recruited about half of the targeted 630 CKD stage 4 subjects since October 2021 (details on […]
Kibow Biotech Announces FDA Approval of IND to Initiate Phase II Clinical Trial of US-APR2020 to Treat Chronic Kidney Disease Stage IV
Kibow Biotech, Inc., a clinical-stage biotechnology company pioneering the discovery and development of probiotics and prebiotics (synbiotics) for the treatment of kidney diseases beyond gut health, today announced that the U.S.
Kibow® Biotech Inc Supports President Trump’s Executive Order to Advance American Kidney Health with Expanded Plans to Develop Live Bio Therapeutic Product (LBP) as Drugs to Slow Progression to Dialysis
Kibow® Biotech Inc Supports President Trump’s Executive Order to Advance American Kidney Health with Expanded Plans to Develop Live Bio Therapeutic Product (LBP) as Drugs to Slow Progression to Dialysis “The Trump administration has announced an ambitious plan to change treatment for kidney disease in the United States. President Trump signed an executive order on […]